Affymax (OTCMKTS:AFFY) Stock Price Breaks Above Two Hundred Day Moving Average – What’s Next?

Shares of Affymax Inc. (OTCMKTS:AFFY – Get Free Report) passed above its 200-day moving average during trading on Thursday. The stock has a 200-day moving average of $0.00 and traded as high as $0.0017. Affymax shares last traded at $0.0017, with a volume of 3,200 shares trading hands.

Affymax Stock Up 2,347.1%

About Affymax

(Get Free Report)

Affymax, Inc was a biotechnology company focused on developing novel therapies for serious medical conditions. The company used drug-discovery and molecular engineering technologies to identify and advance pharmaceutical candidates, with an emphasis on treatments for hematology and related disorders.

Affymax’s principal product was peginesatide, an anemia treatment marketed in the United States under the brand name Omontys. The U.S. Food and Drug Administration approved Omontys in 2012 for the treatment of anemia associated with chronic kidney disease.

Further Reading

• Five stocks we like better than Affymax
• 3 Unique ETFs With Strong Momentum for the End of the Year
• 3 Beaten-Down Biotech Stocks With Triple-Digit Upside and Big Catalysts Ahead
• Schneider Just Paid Up for PTC—Is the SaaSpocalypse Overdone?
• Delta Air Lines Faces a Fuel Crisis—But There’s a Silver Lining